The results demonstrated that genetic liability to type 2 diabetes was significantly associated with an elevated risk of 12 gastrointestinal conditions, including gastroesophageal reflux disease, gastric ulcer, acute gastritis, chronic gastritis, irritable bowel syndrome, diverticular disease, acute pancreatitis, cholelithiasis, cholelithiasis with cholecystitis, nonalcoholic fatty liver disease, liver cirrhosis, and ulcerative colitis [70]
A Review of Ovary Torsion. National Center for Biotechnology Information , www.ncbi.nlm.nih.gov/pmc/articles/PMC5615993/
GLP-1: Slows digestion Lowers appetite Helps the body release insulin only when blood sugar is high GLP-1 medications mimic these effects
Finally, documenting early real-world outcomes fills an important knowledge gap, as most clinical trials primarily report long-term results